Kimia
7 known investors
Find your way into Kimia
Sign up to see every warm intro you have to Kimia
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kimia team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Kimia is a therapeutics company developing new drugs through its ATLAS platform, working with partners in the pharmaceutical and biotechnology industries. It focuses on improving outcomes for patients.
Founders & leadership
Investors · 7
How we know: funding news · Not right? Tell us
How we know: The Column Group's portfolio page · a partner's Signal profile · funding news · the VCSheet dataset · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: funding news · open dataset · 5k.vc investor directory · Not right? Tell us
Funding
SEC filings, press & company announcements$7M disclosed across 1 of 2 rounds · 2026
- $7MSeedApr 2026 · 3 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Kimia do?
- Kimia is a therapeutics company developing new drugs through its ATLAS platform, working with partners in the pharmaceutical and biotechnology industries. It focuses on improving outcomes for patients.
- Who founded Kimia?
- Kimia was founded by Stig Hansen.
- Who are Kimia's investors?
- Kimia's investors include AirTree Ventures, Horizons Ventures, The Column Group, Blackbird Ventures, DIMENSION, Dimension Capital, Skip Capital.
- How much funding has Kimia raised?
- Kimia has disclosed $7M raised across 1 of its 2 known rounds.





